Chlorthalidone and HCTZ Impacts on Platelet Activation
NCT02100462
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Chlorthalidone 12.5 mg
DRUG:
Hydrochlorothiazide 25 mg
DRUG:
Aspirin 81 mg
Sponsor
Creighton University
Collaborators
[object Object]